Isolated human tau peptide

US6010913A · kind A · utility

Assignee

• N.V. Innogenetics S.A. · BE

Inventors

• Marc Vandermeeren · Geel, BE
• Marc Mercken · Turnhout, BE
• Eugeen Vanmechelen · Zevergem, BE
• Andre Van De Voorde · Lokeren, BE

Key dates

• Filing date: Jan 19, 1995
• Grant date: Jan 4, 2000
• Expiry date: Jan 19, 2015

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S436/811
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The invention deals with isolated human tau peptide epitopes of SEQ ID Nos: 1 to 4, 7 and 15 to 20 which have the capability of binding AT120 monoclonal antibody.